Darifenacin for the treatment of overactive bladder.

about

An overview of the clinical use of antimuscarinics in the treatment of overactive bladder

P2860

Q35042575-09ADD0A3-C089-4C5C-97EC-7558B28B3623

P2860

Darifenacin for the treatment of overactive bladder.

Item

http://www.wikidata.org/entity/Q37608354

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

Darifenacin for the treatment of overactive bladder.

@en

Darifenacin for the treatment of overactive bladder.

@nl

type

Item

label

Darifenacin for the treatment of overactive bladder.

@en

Darifenacin for the treatment of overactive bladder.

@nl

prefLabel

Darifenacin for the treatment of overactive bladder.

@en

Darifenacin for the treatment of overactive bladder.

@nl

P1476

Darifenacin for the treatment of overactive bladder.

@en

P2093

François Haab

http://www.w3.org/2001/XMLSchema#string

P2860

How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study

An investigation of dose titration with darifenacin, an M3-selective receptor antagonist.

Population pharmacokinetic modelling of darifenacin and its hydroxylated metabolite using pooled data, incorporating saturable first-pass metabolism, CYP2D6 genotype and formulation-dependent bioavailability

Factors involved in the success of antimuscarinic treatment.

M(3) receptor antagonism by the novel antimuscarinic agent solifenacin in the urinary bladder and salivary gland.

Pharmacodynamic effects of darifenacin, a muscarinic M selective receptor antagonist for the treatment of overactive bladder, in healthy volunteers.

Assessment of an electronic daily diary in patients with overactive bladder.

Antimuscarinics for treatment of overactive bladder.

Darifenacin, an M3 selective receptor antagonist, is an effective and well-tolerated once-daily treatment for overactive bladder.

Oxybutynin and cognitive dysfunction.

P304

331-343

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/17455057.1.3.331

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2005-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19803875

http://www.w3.org/2001/XMLSchema#string

Darifenacin for the treatment of overactive bladder.

about

P2860

P2860

Darifenacin for the treatment of overactive bladder.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698